Hazelnut (Corylus avellana)
Hazelnuts, also called filberts, are the nuts of the hazel tree Corylus avellana, eaten raw or roasted and sold as flour. Per 100 g, USDA lists 628 kcal and 60.8 g of mostly monounsaturated fat, plus 15.0 mg of vitamin E as alpha-tocopherol and 9.7 g of fiber. In a pooled analysis of 3 randomized studies, LDL cholesterol was slightly lower with hazelnuts, though most single controlled trials found no difference. In randomized trials, hazelnuts did not change blood pressure, fasting blood sugar or inflammation markers against nut-free diets, and adding about 42 g a day for 12 weeks did not raise body weight more than chocolate, potato chips or no snack. FDA will consider enforcement discretion for a qualified claim about most nuts, including hazelnuts. Tree nuts, hazelnut among them, are one of the nine major US food allergens, and in adults hazelnut allergy is often linked to birch pollen allergy.
Benefits
LDL and total cholesterol, blood lipid markers
A pooled analysis of 3 randomized studies against nut-free diets found LDL cholesterol 0.15 mmol/L lower with hazelnuts, while total cholesterol, HDL and triglycerides did not change significantly. In 48 adults with mildly raised cholesterol, 30 g a day lowered total and LDL cholesterol from baseline, but the trial had no nut-free phase. In a later review, 2 of 9 trials with a no-nut control found lower total and LDL cholesterol.
Blood pressure in hazelnut trials
A systematic review found 3 trials that compared hazelnuts with a nut-free control, and none showed a blood pressure difference. In 107 adults with overweight, 30 or 60 g a day for 12 weeks did not change blood pressure compared with no nuts. Lower systolic pressure appeared only as changes from baseline in studies without a nut-free control.
Body weight when hazelnuts are added to the diet
In 118 adults, adding about 42 g of hazelnuts a day for 12 weeks changed weight by 0.83 kg, against 0.59 kg with chocolate, 0.50 kg with potato chips and 0.46 kg with no snack, with no significant difference between groups. In adults with overweight, 30 or 60 g a day for 12 weeks did not change body composition compared with no nuts.
Fasting blood sugar and the glucose response to bread
In 50 adults with type 2 diabetes, swapping 10% of daily energy for hazelnuts for 8 weeks did not change fasting blood sugar compared with usual diet. In 23 women, corn bread made with 15 g of hazelnut flour gave a smaller blood glucose rise than plain corn bread in single-meal tests, a marker; 30 g gave less benefit.
Vitamin E status and diet quality
Per 100 g, USDA lists 15.0 mg of vitamin E as alpha-tocopherol. In 32 older adults eating about 57 g a day for 16 weeks, a urine marker of vitamin E rose while plasma alpha-tocopherol did not, in a study without a control group. Against calorie-matched chocolate or chips, hazelnuts raised intakes of vitamin E and monounsaturated fat.
Inflammation and blood vessel markers
In 107 adults with overweight, 30 or 60 g a day for 12 weeks did not change CRP, IL-6, ICAM-1 or VCAM-1 compared with no nuts. In 21 adults with high cholesterol, a 4 week hazelnut diet between two nut-free periods improved flow-mediated dilation, CRP and oxidized LDL, but this single-group study was not randomized.
Mechanism of action
Monounsaturated fat in place of saturated fat and carbohydrate
Most hazelnut fat is monounsaturated oleic acid (45.4 g per 100 g). When adults ate hazelnuts as a daily snack, the share of energy from saturated fat and carbohydrate fell and from monounsaturated fat rose, and in children the monounsaturated share of red blood cell membrane fat rose more than with diet advice alone.
Alpha-tocopherol supply
Hazelnuts carry vitamin E mainly as alpha-tocopherol (15.0 mg per 100 g, with gamma-tocopherol listed as 0 mg by USDA), unlike walnuts. Plasma alpha-tocopherol rose from baseline with 30 g a day in one trial but not with about 57 g a day in older adults, where only a urinary metabolite rose. Effects of this on health outcomes are not established.
Skin, form and processing
Hazelnuts with or without the brown skin gave similar lipid results in children, and whole, sliced and ground hazelnuts did not differ in adults. Raw and dry roasted, lightly salted hazelnuts gave similar total and LDL cholesterol, though HDL cholesterol and triglycerides were lower after the roasted form.
Clinical trials
Randomized, controlled parallel trial with 3 arms: no nuts, 30 g a day or 60 g a day of hazelnuts for 12 weeks; inflammatory markers, cell adhesion molecules and body composition were the stated aims; funding not stated in the abstract (Tey et al. 2013, J Nutr)
107 adults with overweight or obesity and normal cholesterol in Dunedin, New Zealand.
After adjustment for baseline values, age, sex and BMI, no follow-up outcome differed between groups (all P of 0.10 or more), including hs-CRP, IL-6, ICAM-1, blood pressure, lipids and body composition; VCAM-1 tended to be lower with 60 g (P = 0.07). Diet quality improved with dose. Desire and liking for nuts held steady at 30 g but fell over time at 60 g.
Randomized, controlled parallel trial with 4 arms: about 1100 kJ a day of hazelnuts (42 g), milk chocolate (50 g) or potato chips (50 g), or no added food, for 12 weeks; body weight, body composition and blood lipids were the main outcomes; registered ACTRN12609000265279; funded by a University of Otago Research Grant, with hazelnuts purchased (Tey et al. 2011, J Nutr Metab)
118 non-obese adults in Dunedin, New Zealand, in the intention-to-treat analysis (32 in the hazelnut group).
Weight changed by 0.83 kg with hazelnuts, 0.59 kg with chocolate, 0.50 kg with chips and 0.46 kg with no snack (overall P = 0.655), and body fat did not differ. Total cholesterol fell more with hazelnuts than with chocolate (P = 0.006) in the per-protocol analysis, with a trend against no snack (P = 0.057). Vitamin E and monounsaturated fat intakes rose in the hazelnut group.
Randomized crossover trial with three 4 week phases of 30 g a day of ground, sliced or whole hazelnuts added to the usual diet, comparing nut forms with no nut-free phase; funding not stated in the abstract (Tey et al. 2011, Eur J Clin Nutr)
48 adults with mildly raised cholesterol in New Zealand.
No outcome differed between the three forms (all P of 0.159 or more). Compared with baseline, total cholesterol, LDL cholesterol, apoB100 and the total to HDL cholesterol ratio were lower and HDL cholesterol (P = 0.023) and plasma alpha-tocopherol (P = 0.005) higher at the end of each phase, with no change in body weight (P = 0.813). Without a nut-free control, these are changes from baseline.
Nonrandomized single-group study with a double control sandwich design: control diet for 4 weeks, hazelnut-enriched diet (hazelnuts at 18 to 20% of daily energy) for 4 weeks, then control diet again for 4 weeks, all isoenergetic; funding not stated in the abstract (Orem et al. 2013, J Clin Lipidol)
21 adults with high cholesterol (18 men, 3 women) in Trabzon, Turkey.
Compared with the first control period, the hazelnut diet raised flow-mediated dilation by 56.6% and lowered total cholesterol 7.8%, triglycerides 7.3% and LDL cholesterol 6.17%, while HDL rose 6.07%. Oxidized LDL, hs-CRP and sVCAM-1 were lower than in both control periods, and the changes reversed after 4 weeks without hazelnuts. Everyone received the diets in the same order.
Randomized, single-blind, controlled three-arm parallel trial; hazelnuts with skin or without skin (15 to 30 g a day by body weight) plus dietary advice, or dietary advice only, for 8 weeks; registered ISRCTN12261900; Europe PMC lists a European Regional Development Fund grant (FA270-264C) (Deon et al. 2018, Clin Nutr)
66 children and adolescents with primary hyperlipidemia in Turin, Italy.
LDL cholesterol, the HDL to LDL ratio and non-HDL cholesterol changed over time (P of 0.001 or less), but treatment and the time by treatment interaction were not significant, so lipid changes did not differ from diet advice alone. Monounsaturated fat (P = 0.008) and the monounsaturated to saturated ratio (P = 0.002) in red blood cell membranes rose more with hazelnuts than in controls.
Pre-post intervention study without a control group; about 57 g a day of hazelnuts for 16 weeks; primary end points were changes in plasma alpha-tocopherol, urinary alpha-CEHC and serum magnesium; registered NCT03485989 in March 2018 after the June 2016 start, with the Hazelnut Marketing Board listed as collaborator (Michels et al. 2018, J Nutr)
32 healthy adults (22 women), mean age 63, in Oregon, USA.
Urinary alpha-CEHC, a vitamin E metabolite, rose from 0.84 to 1.14 micromol/g creatinine (P = 0.0006), but plasma alpha-tocopherol did not change. Serum magnesium rose 2.1% (P = 0.05), fasting glucose fell 3.4% and LDL cholesterol 6.0%. Blood pressure, insulin, hs-CRP, triglycerides and HDL did not change. Without a control group, these are changes from baseline.
Randomized controlled parallel trial; hazelnuts replacing 10% of daily energy (about 29 g a day) versus the usual diet for 8 weeks; fasting blood sugar and blood lipids were the outcomes; the paper states no outside source of support (Damavandi et al. 2013, J Res Med Sci)
50 adults with type 2 diabetes (16 men, 34 women, mean age 55.7) at Tehran University of Medical Sciences, Iran; 48 analyzed.
Fasting blood sugar, total cholesterol, LDL cholesterol and triglycerides did not differ between groups or change within groups. HDL cholesterol differed between groups (P = 0.009) because it fell in the control group and held steady with hazelnuts. Body weight did not change.
Single-meal tests on separate weeks, each portion with 50 g of digestible carbohydrate: glucose syrup, plain corn bread, corn bread with 15 g of hazelnut flour and corn bread with 30 g of hazelnut flour, given in that order by week per the abstract; registered NCT06382506 (Cesur et al. 2025, Int J Food Sci Nutr)
23 women in Turkey.
The bread with 15 g of hazelnut flour gave a significantly lower blood glucose area under the curve and glycemic index than the other breads (p < 0.05). Adding 30 g of hazelnut flour gave less benefit than 15 g. This is a short-term glucose marker after one meal.
Side effects and drug interactions
Common Potential side effects
Important Drug interactions
Frequently asked questions about Hazelnut (Corylus avellana)
What can a hazelnut label say about the heart?
Hazelnuts were among the nuts in the 2003 petition and were not excluded, so FDA will consider enforcement discretion for this qualified claim: "Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts [, such as name of specific nut,] as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease. [See nutrition information for fat content.]" FDA chose a qualified claim because it found no significant scientific agreement for an authorized one. For whole or chopped nuts the claim adds the fat disclosure; nut-containing products must contain at least 11 g of qualifying nuts per reference amount customarily consumed and meet the low saturated fat and low cholesterol definitions.
How many hazelnuts were used in the studies?
Most adult trials used 30 to 60 g a day for 4 to 16 weeks, or hazelnuts at 10 to 20% of daily energy, and children received 15 to 30 g a day by body weight. The FDA nut claim refers to 1.5 ounces, about 42 g. USDA lists one ounce as about 21 kernels and 178 kcal.
Do hazelnuts cause weight gain?
Not in the trials cited here. Adding about 42 g a day for 12 weeks changed weight no more than calorie-matched chocolate, potato chips or no snack, and 30 or 60 g a day did not change body composition compared with no nuts. Hazelnuts are calorie dense, about 178 kcal per ounce, and in the 42 g trial they were added with no diet advice.
Are hazelnut flour, sliced hazelnuts and roasted hazelnuts the same as whole ones?
Ground, sliced and whole hazelnuts gave the same blood lipid results in a 4 week crossover trial, though people liked whole nuts best. Dry roasted, lightly salted hazelnuts gave similar total and LDL cholesterol to raw ones. Hazelnut butter and sweetened hazelnut spreads were not tested in the trials cited here.
Who should avoid hazelnuts?
Anyone who has reacted to hazelnuts or been told to avoid tree nuts. In adults, hazelnut allergy often goes with birch pollen allergy and most allergic adults have only subjective symptoms, but in children and in people sensitized to the storage proteins Cor a 9 and Cor a 14, objective or severe reactions are more common. An allergist can test which pattern applies.
What is Hazelnut?
Hazelnuts, also called filberts, are the nuts of the hazel tree Corylus avellana, eaten raw or roasted and sold as flour. Per 100 g, USDA lists 628 kcal and 60.8 g of mostly monounsaturated fat, plus 15.0 mg of vitamin E as alpha-tocopherol and 9.7 g of fiber.
What is Hazelnut used for?
NutraSmarts does not list Hazelnut under a health category. What the research covers: A pooled analysis of 3 randomized studies against nut-free diets found LDL cholesterol 0.15 mmol/L lower with hazelnuts, while total cholesterol, HDL and triglycerides did not change significantly.
What is the recommended dosage of Hazelnut?
The clinically studied dose is Whole, sliced or ground hazelnuts: 30 g a day for 4 weeks; 42 g a day or 30 and 60 g a day for 12 weeks; about 57 g a day for 16 weeks; 15 to 30 g a day in children; or 10 to 20% of daily energy. The FDA nut claim refers to 1.5 ounces (about 42 g) a day. Always follow the product label and check with a healthcare provider for personal advice.
Is Hazelnut safe, and does it have side effects?
Side effects and cautions reported for Hazelnut include: Tree nut allergy: hazelnut is a tree nut, and FDA lists tree nuts among the nine major food allergens that labels must name, with reactions ranging from hives and lip swelling to life-threatening anaphylaxis. It may also interact with some medications. Hazelnut is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.
Does Hazelnut interact with any medications?
Possible interactions include: Cholesterol-lowering medicines: hazelnut diets lowered LDL cholesterol slightly in small trials. Do not use hazelnuts in place of prescribed treatment or change a dose on your own. If you take prescription medication, check with a pharmacist or doctor before using it.
How strong is the scientific evidence for Hazelnut?
NutraSmarts rates the evidence for Hazelnut as Limited (2 out of 5). It is backed by 8 study summaries and 16 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.
References(16 citations)
Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.
- Effects of Hazelnut Consumption on Blood Lipids and Body Weight: A Systematic Review and Bayesian Meta-Analysis. Nutrients. 2016;8(12):747. doi: 10.3390/nu8120747.PubMedUsed to support: Bayesian random-effects meta-analysis: 9 studies (425 participants, 29 to 69 g a day for 28 to 84 days) were reviewed and 3 randomized studies with nut-free control diets were pooled (Damavandi 2013, Tey 2011 in J Nutr Metab, and Tey 2013 with its 30 and 60 g arms entered separately). LDL cholesterol was 0.150 mmol/L lower with hazelnuts (95% HPD -0.308 to -0.003); total cholesterol showed a trend (-0.127 mmol/L, 95% HPD -0.284 to 0.014), and HDL cholesterol, triglycerides and BMI did not change. The full text states no heterogeneity index was given because only 3 studies were pooled. The authors declared no competing interests. A pooled analysis, not a new trial.
- Effects of Hazelnut Consumption on Cardiometabolic Risk Factors and Acceptance: A Systematic Review. Int J Environ Res Public Health. 2022;19(5):2880. doi: 10.3390/ijerph19052880.PubMedUsed to support: Qualitative systematic review of 22 hazelnut intervention studies (25 publications), many with single-group or sequential designs. Of 9 studies with a no-nut control, 2 reported lower total and LDL cholesterol than control; none of the 3 controlled blood pressure studies showed a difference; 9 of 10 controlled studies found no body weight or composition difference; only 1 of 7 studies measuring fasting glucose (a single-group study) found it lower; 6 of 7 studies found no improvement in inflammatory markers. The authors judge study design limitations make interpretation problematic. No external funding; no conflicts declared.
- The dose of hazelnuts influences acceptance and diet quality but not inflammatory markers and body composition in overweight and obese individuals. J Nutr. 2013;143(8):1254-62. doi: 10.3945/jn.113.174714.PubMedUsed to support: Randomized, controlled 12 week parallel trial in 107 adults with overweight or obesity and normal cholesterol: no nuts, 30 g a day or 60 g a day of hazelnuts. After adjustment, no follow-up outcome differed between groups (all P of 0.10 or more), including hs-CRP, IL-6, ICAM-1, blood pressure, lipids, apolipoproteins and body composition; VCAM-1 tended to be lower at 60 g (P = 0.07). Diet quality improved with dose; desire and liking fell over time at 60 g. Abstract read; funding is not stated in it.
- Nuts improve diet quality compared to other energy-dense snacks while maintaining body weight. J Nutr Metab. 2011;2011:357350. doi: 10.1155/2011/357350.PubMedUsed to support: Randomized, controlled 12 week parallel trial in 118 non-obese adults: about 1100 kJ a day of hazelnuts (42 g), chocolate (50 g) or potato chips (50 g), or no added snack. Body weight changed by 0.83, 0.59, 0.50 and 0.46 kg (overall P = 0.655) and body composition did not differ; total cholesterol fell more with hazelnuts than chocolate (P = 0.006, per protocol) with a trend against control (P = 0.057); vitamin E and monounsaturated fat intakes rose in the hazelnut group. One hazelnut-group participant stopped after an adverse event. PMC full text read: registered ACTRN12609000265279, funded by a University of Otago Research Grant, hazelnuts purchased, no conflicts.
- Effects of different forms of hazelnuts on blood lipids and α-tocopherol concentrations in mildly hypercholesterolemic individuals. Eur J Clin Nutr. 2011;65(1):117-24. doi: 10.1038/ejcn.2010.200.PubMedUsed to support: Randomized crossover trial in 48 adults with mildly raised cholesterol: 30 g a day of ground, sliced or whole hazelnuts for 4 weeks each, with no nut-free phase. Outcomes did not differ between forms (all P of 0.159 or more). Compared with baseline, total and LDL cholesterol, apoB100 and the total to HDL cholesterol and apoB100 to apoA1 ratios were lower, and HDL cholesterol (P = 0.023) and plasma alpha-tocopherol (P = 0.005) higher, with no change in body weight (P = 0.813). Abstract read; funding is not stated in it.
- Do dry roasting, lightly salting nuts affect their cardioprotective properties and acceptability? Eur J Nutr. 2017;56(3):1025-1036. doi: 10.1007/s00394-015-1150-4.PubMedUsed to support: Randomized crossover trial in 72 adults: 30 g a day of raw or dry roasted, lightly salted hazelnuts for 28 days each. Body composition, blood pressure, total and LDL cholesterol, apoA1, apoB100, glucose and alpha-tocopherol did not differ between forms (all P of 0.054 or more); HDL cholesterol (P = 0.037) and triglycerides (P < 0.001) were lower after the roasted form. Compared with baseline, both forms raised HDL cholesterol and apoA1 and lowered the total to HDL ratio and systolic pressure. Europe PMC lists the National Heart Foundation of New Zealand as funder.
- Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects. J Clin Lipidol. 2013;7(2):123-31. doi: 10.1016/j.jacl.2012.10.005.PubMedUsed to support: Single-group, nonrandomized double control sandwich study in 21 adults with high cholesterol: 4 weeks of control diet, 4 weeks of hazelnut-enriched diet (18 to 20% of energy from hazelnuts), then 4 weeks of control diet, all isoenergetic. Compared with the first control period, flow-mediated dilation rose 56.6%, total cholesterol fell 7.8%, triglycerides 7.3% and LDL cholesterol 6.17%, and HDL rose 6.07%; oxidized LDL, hs-CRP and sVCAM-1 were lower than in both control periods, and effects reversed after the hazelnut period. Abstract read; funding is not stated in it.
- Effect of hazelnut on serum lipid profile and fatty acid composition of erythrocyte phospholipids in children and adolescents with primary hyperlipidemia: A randomized controlled trial. Clin Nutr. 2018;37(4):1193-1201. doi: 10.1016/j.clnu.2017.05.022.PubMedUsed to support: Randomized, single-blind, controlled 8 week three-arm trial in 66 children and adolescents with primary hyperlipidemia: hazelnuts with skin or without skin (15 to 30 g a day by body weight) or dietary advice only. LDL cholesterol, HDL to LDL ratio and non-HDL cholesterol changed over time (P of 0.001 or less) without a significant treatment or time by treatment effect; erythrocyte monounsaturated fat (P = 0.008) and the monounsaturated to saturated ratio (P = 0.002) rose more with hazelnuts. Registered ISRCTN12261900; Europe PMC lists a European Regional Development Fund grant (FA270-264C).
- Daily Consumption of Oregon Hazelnuts Affects α-Tocopherol Status in Healthy Older Adults: A Pre-Post Intervention Study. J Nutr. 2018;148(12):1924-1930. doi: 10.1093/jn/nxy210.PubMedUsed to support: Pre-post study without a control group in 32 healthy older adults (22 women, mean age 63): about 57 g a day of hazelnuts for 16 weeks. Urinary alpha-CEHC rose from 0.84 to 1.14 micromol/g creatinine (P = 0.0006); plasma alpha-tocopherol, blood pressure, insulin, hs-CRP, triglycerides and HDL did not change; serum magnesium rose 2.1% (P = 0.05), fasting glucose fell 3.4% (P = 0.03) and LDL cholesterol 6.0% (P = 0.02). ClinicalTrials.gov NCT03485989 (first submitted March 2018, study start June 2016) lists Oregon State University as sponsor and the Hazelnut Marketing Board as collaborator.
- Effects of hazelnuts consumption on fasting blood sugar and lipoproteins in patients with type 2 diabetes. J Res Med Sci. 2013;18(4):314-21. PMCID: PMC3793377.PubMedUsed to support: Randomized controlled 8 week parallel trial in 50 adults with type 2 diabetes (48 analyzed): hazelnuts replacing 10% of daily energy (about 29 g a day) versus usual diet. Fasting blood sugar, total and LDL cholesterol and triglycerides did not differ between or within groups; HDL cholesterol differed (P = 0.009) because it fell in the control group. Body weight did not change. PMC full text read: source of support nil; no conflicts declared.
- Can hazelnut flour added to gluten-free corn flour in different amounts cause differences in blood glucose fluctuations? Int J Food Sci Nutr. 2025;76(1):84-92. doi: 10.1080/09637486.2024.2435841.PubMedUsed to support: Single-meal glucose tests in 23 women: glucose syrup, plain corn bread, and corn bread with 15 g or 30 g of hazelnut flour, each with 50 g of digestible carbohydrate, given on successive weeks in that order per the abstract. The 15 g hazelnut flour bread gave a significantly lower glucose area under the curve and glycemic index than the other breads (p < 0.05), and the effect lessened above 15 g. Registered NCT06382506. Abstract read.
- Hazelnut allergy differs between children and adults in frequency of severity, aetiology and relevance of diagnostic parameters. Clin Exp Allergy. 2014;44(12):1539-45. doi: 10.1111/cea.12440.PubMedUsed to support: Clinic study comparing 120 adults who had a double-blind placebo-controlled hazelnut challenge with 151 previously challenged children in the Netherlands. Allergy was confirmed in 95 of 120 adults (79%); 77% of allergic adults had only subjective symptoms, while 63% of allergic children had objective symptoms, and severe allergy was more frequent in younger children. Concomitant birch pollen allergy was present in 82% of allergic adults and 39% of allergic children. Abstract read.
- Component-resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy. Allergy. 2018;73(3):549-559. doi: 10.1111/all.13328.PubMedUsed to support: European study of 423 patients reporting hazelnut allergy in 12 cities, with symptoms graded during double-blind placebo-controlled food challenges: IgE to the storage proteins Cor a 9 (odds ratio 10.5) and Cor a 14 (odds ratio 10.1) was positively associated, and IgE to the allergen Cor a 1 negatively associated (odds ratio 0.14), with severe symptoms. A model adding atopic dermatitis, pollen allergy and walnut IgE predicted severity best. Abstract read.
- Qualified Health Claims: Letter of Enforcement Discretion, Nuts and Coronary Heart Disease (Docket No. 02P-0505). U.S. Food and Drug Administration. 2003;Letter dated July 14, 2003, to the International Tree Nut Council Nutrition Research and Education Foundation; archived FDA page, accessed 2026..SourceUsed to support: Not PubMed-indexed; FDA letter read via its archived page. The petition named peanuts and nine tree nuts: almonds, Brazil nuts, cashew nuts, hazelnuts, macadamia nuts, pecans, pine nuts, pistachio nuts and walnuts. FDA excluded Brazil nuts, macadamia nuts, cashew nuts and some varieties of pine nuts because they exceed saturated fat disqualifying levels; hazelnuts were not excluded. FDA found no significant scientific agreement for an authorized claim and said it would consider enforcement discretion for this qualified claim on whole or chopped nuts and qualifying nut-containing products: "Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts [, such as name of specific nut,] as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease. [See nutrition information for fat content.]" The fat disclosure applies to whole or chopped nuts; nut-containing products need at least 11 g of qualifying nuts per RACC and must meet the low saturated fat and low cholesterol definitions.
- FoodData Central: Nuts, hazelnuts or filberts (SR Legacy, FDC ID 170581). USDA FoodData Central. 2019;SR Legacy food 12120; last updated April 1, 2019. Accessed 2026..SourceUsed to support: Not PubMed-indexed; USDA nutrient database entry read via the FoodData Central site data (scientific name listed as Corylus spp., with Corylus avellana as attribute). Per 100 g: 628 kcal, 15.0 g protein, 60.8 g fat (4.46 g saturated, 45.7 g monounsaturated including 45.4 g oleic acid, 7.92 g polyunsaturated), 16.7 g carbohydrate, 9.7 g fiber, 15.0 mg alpha-tocopherol, 0 mg gamma-tocopherol, 163 mg magnesium, 6.18 mg manganese, 1.72 mg copper, 113 mcg folate and 102 mg beta-sitosterol. Portion: 1 oz (21 whole kernels) 28.35 g.
- Food Allergies. U.S. Food and Drug Administration. 2026;Web page, content current as of 03/11/2026. Accessed 2026..SourceUsed to support: Not PubMed-indexed; FDA consumer page read in 2026. Lists the nine major food allergens (milk, eggs, fish, Crustacean shellfish, tree nuts, peanuts, wheat, soybeans and sesame), states that labels must name the type of tree nut (examples given are almonds, pecans and walnuts; hazelnuts are not named on the page), and notes that reactions range from hives and lip swelling to life-threatening anaphylaxis.